Home › Funds › LGT Group Foundation › WST

LGT Group Foundation position in WST

WEST PHARMACEUTICAL SVSC INC · Health Care

LGT Group Foundation reported holding 228,311 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q3 2026 13F filing — a position valued at US$84.6M, representing 0.77% of its reported portfolio and ranking #29 among its reported holdings. LGT Group Foundation has disclosed WST holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)228.31K sh
Reported value held$84.65M
Portfolio Weight0.77%
First reportedQ2 2024
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How LGT Group Foundation's WST position evolved

LGT Group Foundation first disclosed a stake in WST in Q2 2024 at 209,034 shares (US$68.9M). The position peaked in Q3 2026 at 228,311 shares, worth US$84.6M. Across 10 filings, LGT Group Foundation increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 228,311 shares valued at US$84.6M — an increase of 4,946 shares quarter over quarter.. Notable position changes include a 49% trim in Q3 2024 (shares rose 9% over the following quarter), a 106% increase in Q1 2025 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 209.03K $68.85M New
Q3 2024 107.37K $32.19M Reduce
Q4 2024 107.12K $35.09M Hold
Q1 2025 221.04K $49.49M Add
Q2 2025 223.93K $49.00M Add
Q3 2025 209.59K $56.89M Reduce
Q4 2025 205.09K $56.78M Reduce
Q1 2026 203.56K $51.02M Reduce
Q2 2026 223.37K $80.19M Add
Q3 2026 228.31K $84.65M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WST and 13F data

WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 28 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$744.4M), BROWN ADVISORY INC (US$346.9M), Longview Partners (Guernsey) LTD (US$343.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WST

All WST fund holders →

FAQ

How long has LGT Group Foundation held WST?

LGT Group Foundation has disclosed WST holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is LGT Group Foundation's current position in WST?

As of Q3 2026, LGT Group Foundation holds 228.31K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $84.65M, representing 0.77% of its reported portfolio and ranking #29.

Has LGT Group Foundation been buying or selling WST?

In the latest 13F filing (Q3 2026), LGT Group Foundation increased its position in WST. The position peaked in Q3 2026 at 228.31K shares.

Which other funds hold WST?

Other major institutional holders of WST include Artisan Partners Limited Partnership, BROWN ADVISORY INC, Longview Partners (Guernsey) LTD, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.